Cargando…
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Non-structural protein 3 (nsp3) from all coronaviruses (CoVs) contains a conserved macrodomain, known as Mac1, that has been proposed as a potential therapeutic target for CoVs due to its critical role in viral pathogenesis. Mac1 is an ADP-ribose binding protein and ADP-ribosylhydrolase that promote...
Autores principales: | O’Connor, Joseph J., Ferraris, Dana, Fehr, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610136/ https://www.ncbi.nlm.nih.gov/pubmed/37887737 http://dx.doi.org/10.3390/pathogens12101221 |
Ejemplares similares
-
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
por: Roy, Anu, et al.
Publicado: (2022) -
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice
por: Alhammad, Yousef M., et al.
Publicado: (2023) -
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
por: Alhammad, Yousef M., et al.
Publicado: (2023) -
Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain
por: Sherrill, Lavinia M., et al.
Publicado: (2022) -
Transmission of SARS-CoV-2: an update of current literature
por: Patel, Kishan P., et al.
Publicado: (2020)